You are here

  • Home
  • Impact
  • Publications
  • Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective a4B2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders

Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective a4B2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders

Mazurov, A., Miao, L., Bhatti, B., Strachan, J., Akireddy, S., Murthy, S., ... Yohannes, D. (2012). Discovery of 3-(5-chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane (TC-6683, AZD1446), a novel highly selective a4B2 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders. Journal of Medicinal Chemistry, 55(22), 9793 - 9809.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Chapter

Food acquisition coping strategies used by food insecure adults in New Jersey
Article

Electrochemical carbon dioxide reduction to isopropanol using novel carbonized copper metal organic framework derived electrodes
Article

Parental views on newborn next generation sequencing
Article

Design for a mail survey to determine prevalence of SARS-CoV-2 (COVID-19) antibodies in the United States

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept